Its role in myelomagenesis is supported by SLAMF7 overexpression inducing increased MM cell adhesion to bone marrow stromal cells, cyclin D2-dependent proliferation and VEGF-induced bone marrow angiogenesis in preclinical models [98]. Here, SLAMF7 is linked to Miyoshi myopathy.